Literature DB >> 6603094

Granulocyte specific antinuclear antibodies in ulcerative colitis. Aid in differential diagnosis of inflammatory bowel disease.

H Nielsen, A Wiik, J Elmgreen.   

Abstract

40 patients with ulcerative colitis (UC) and 35 patients with Crohn's disease (CD) were studied for the occurrence of granulocyte specific (GS-) antinuclear antibodies (ANA) and organ-non-specific (ON-) ANA. The predominant immunoglobulin class of GS-ANA in UC was IgG, present in 25% of the patients, but only in 3% of the patients with CD (p less than 0.02). ON-ANA were are in both groups and did not allow discrimination between these. Both GS-ANA and ON-ANA lacked complement-fixing properties. No relation was found between the types or titres of IgG ANA and sex, age, duration, disease activity or localization in the two groups of patients. The significance of our serologic observations in relation to these disease parameters has to be determined n larger prospective studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603094

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand C        ISSN: 0108-0202


  13 in total

1.  Autoantibodies to molecular targets in neutrophils in patients with ulcerative colitis.

Authors:  J Brimnes; O H Nielsen; A Wiik; N H Heegaard
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

Review 2.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 3.  Antineutrophil cytoplasmic antibody--a useful serological marker for vasculitis.

Authors:  J A Goeken
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

Review 4.  Neutrophil autoantibodies as disease markers for ulcerative colitis.

Authors:  F Shanahan; C Landers; R Duerr; S R Targan
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 5.  The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens.

Authors:  A Wiik; L Stummann; L Kjeldsen; N Borregaard; S Ullman; S Jacobsen; P Halberg
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

6.  Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis.

Authors:  P M Ellerbroek; M Oudkerk Pool; B U Ridwan; K M Dolman; B M von Blomberg; A E von dem Borne; S G Meuwissen; R Goldschmeding
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

Review 7.  Anti-neutrophil cytoplasmic autoantibodies (ANCA) and vasculitis.

Authors:  B Baslund; A Wiik
Journal:  Clin Rev Allergy       Date:  1994

8.  Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role.

Authors:  G Cambridge; D S Rampton; T R Stevens; D A McCarthy; M Kamm; B Leaker
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

9.  A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.

Authors:  J A Savige; B Paspaliaris; R Silvestrini; D Davies; T Nikoloutsopoulos; A Sturgess; J Neil; W Pollock; K Dunster; M Hendle
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

10.  Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

Authors:  L Halbwachs-Mecarelli; P Nusbaum; L H Noël; D Reumaux; S Erlinger; J P Grünfeld; P Lesavre
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.